| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | BG45 |
|---|
| Description | A selective inhibitor of HDAC3 (IC50 = 289 nM) that alone or in combination with bortezomib has been shown to dose-dependently inhibit tumor growth in a mouse model of multiple myeloma |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | HDAC3 inhibitor histone deacetylase tumor multiple myeloma biochemical cancer chromatin research epigenetics modification inhibit HDAC-3 BG-45 class I selectivity HDAC1 HDAC2 HDAC6 HDAC-1 HDAC-2 HDAC-6 bortezomib dose-dependently growth mouse model |
|---|
| Gene, Accession, CAS # | CAS: 926259-99-6 |
|---|
| Catalog # | 16918-10 |
|---|
| Price | |
|---|
| Order / More Info | BG45 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|